FDA Drug Application (020353) for NAPRELAN by ALVOGEN MALTA

Back to FDA Applications sponsored by ALVOGEN MALTA

Application Number020353
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 375MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPRELAN
Active IngredientNAPROXEN SODIUM

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN SODIUM12


Back to FDA Applications sponsored by ALVOGEN MALTA